PT - JOURNAL ARTICLE AU - Alpay, Kemal AU - Hinkka, Tero AU - Lindgren, Antti E AU - Isokangas, Juha-Matti AU - Raj, Rahul AU - Parkkola, Riitta AU - Sinisalo, Matias AU - Numminen, Jussi AU - Pienimäki, Juha-Pekka AU - Saari, Petri AU - Seppänen, Janne AU - Palosaari, Kari AU - Rautio, Riitta TI - Finnish flow diverter study: 8 years of experience in the treatment of acutely ruptured intracranial aneurysms AID - 10.1136/neurintsurg-2021-017641 DP - 2022 Jul 01 TA - Journal of NeuroInterventional Surgery PG - 699--703 VI - 14 IP - 7 4099 - http://jnis.bmj.com/content/14/7/699.short 4100 - http://jnis.bmj.com/content/14/7/699.full SO - J NeuroIntervent Surg2022 Jul 01; 14 AB - Background Flow diversion of acutely ruptured intracranial aneurysms (IAs) is controversial due to high treatment-related complication rates and a lack of supporting evidence. We present clinical and radiological results of the largest series to date.Methods This is a nationwide retrospective study of acutely ruptured IAs treated with flow diverters (FDs). The primary outcome was the modified Rankin Scale (mRS) score at the last available follow-up time. Secondary outcomes were treatment-related complications and the aneurysm occlusion rate.Results 110 patients (64 females; mean age 55.7 years; range 12–82 years) with acutely ruptured IAs were treated with FDs between 2012 and 2020 in five centers. 70 acutely ruptured IAs (64%) were located in anterior circulation, and 47 acutely ruptured IAs (43%) were blister-like. A favorable functional outcome (mRS 0–2) was seen in 73% of patients (74/102). Treatment-related complications were seen in 45% of patients (n=49). Rebleeding was observed in 3 patients (3%). The data from radiological follow-ups were available for 80% of patients (n=88), and complete occlusion was seen in 90% of aneurysms (79/88). The data from clinical follow-ups were available for 93% of patients (n=102). The overall mortality rate was 18% (18/102).Conclusions FD treatment yields high occlusion for acutely ruptured IAs but is associated with a high risk of complications. Considering the high mortality rate of aneurysmal subarachnoid hemorrhage, the prevention of rebleeding is crucial. Thus, FD treatment may be justified as a last resort option.Data are not available for public, however upon a reasonable request it may be provided.